An immunohistochemical and morphological analysis of post-chemotherapy ovarian carcinoma

Abstract

The immunophenotype of post-chemotherapy ovarian carcinomas is very similar to that of native untreated tumours, illustrating that CK7, CA125, WT1, ER, p53 and p16 may be of value in identifying residual tumour cells and in subtyping the neoplasm if a pre-chemotherapy biopsy has not been obtained.

References

Page 1

	Year	Citations
p63, a p53 Homolog at 3q27–29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative Activities Annie Yang, Mourad Kaghad, Yunmei Wang, Molecular Cell Tumor BiologyP53 HomologMedicineApoptosisCell Death	1998	2.1K
Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations A.M. Mandard, Frédéric Dalibard, J.-C. Mandard, Cancer	1994	2K
Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy Karen Becker, James Mueller, Christoph Schulmacher, Cancer Surgical OncologyEsophageal CancerCancer ManagementGastroenterologyPathology	2003	800
The Histologic Type and Stage Distribution of Ovarian Carcinomas of Surface Epithelial Origin Jeffrey D. Seidman, Iren Horkayne‐Szakaly, Moutaz Haiba, International Journal of Gynecological Pathology Tumoral PathologyGynecological SurgeryStage DistributionMedicineHistopathology	2003	556
Pathobiology of preoperative chemotherapy Edwin R. Fisher, Jiping Wang, John Bryant, Cancer	2002	410
Diverse Tumorigenic Pathways in Ovarian Serous Carcinoma Gad Singer, Robert J. Kurman, Hsueh‐Wei Chang, American Journal Of Pathology Diverse Tumorigenic PathwaysGynecologyMedicineTumor BiologyEndocrine-related Cancer	2002	340
Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer. Stephanie Geisler, Per Eystein Lønning, Turid Aas, PubMed Breast OncologyC-erbb-2 ExpressionPathologyCancer BiologyTumor Biology	2001	328
Reactive and Neoplastic Serosal Tissue John W. Bolen, Samuel P. Hammar, Michael A. McNutt The American Journal of Surgical Pathology	1986	254
WT‐1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma Maysa Al‐Hussaini, Adam Stockman, Heather Foster, Histopathology	2004	248
Immunohistochemical Detection of the Wilms' Tumor Gene (WT1) in Epithelial Ovarian Tumors Motohiko Shimizu, Toshihiko Toki, Yasushi Takagi, International Journal of Gynecological Pathology PathologyGynecologyTumor GeneWt1 ExpressionTumor Biology	2000	190

Page 1